Skip to main content

Two new Covid treatments available to people with MS from tomorrow

From tomorrow people with multiple sclerosis (MS) who live in the UK and have Covid-19 will be able to receive one of two new treatments that are only currently available for people in hospital.

Molnupiravir and Ronapreve help stop people getting seriously ill from Covid-19. Molnupiravir is an antiviral which targets Covid-19 and makes it harder for it to make copies of itself. Ronapreve contains two antibodies which minic our body’s own natural ones, and target the virus to stop it infecting our cells.

The NHS should let people with MS know you are eligible for these drugs if you test positive for Covid-19. You will be given a PCR test to keep at home. Take this test if you develop symptoms. If you are positive, you will get a phone call to discuss treatment options.

If you are not contacted within 24 hours of testing positive, call your GP’s surgery or 111.

Read next: Never drinking alcohol raises MS risk

Read next: Treadmill training may help manage cognitive effect in MS